Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Abstract Background Patients with locally advanced rectal cancer (LARC) achieving a pathological complete response (pCR) to neoadjuvant treatment usually have a good prognosis, but only accounted for less than 20%. Case presentation We report a case of a 25-year-old male with LARC treated with neoad...

Full description

Bibliographic Details
Main Authors: Zhenyu Lin, Junli Liu, Li Peng, Dejun Zhang, Ming Jin, Jing Wang, Jun Xue, Hongli Liu, Tao Zhang
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Rectal cancer
Neoadjuvant chemotherapy
BRCA; mutation load
Online Access:http://link.springer.com/article/10.1186/s12885-018-5182-z

Internet

http://link.springer.com/article/10.1186/s12885-018-5182-z

Similar Items